Ardelyx | ARDX - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Amgen USD 1.51B 2.41B 2025-12
Ardelyx USD -37.6M 37.2M 2026-03
aTyr Pharma USD -153K 25.59M 2026-03
Corcept Therapeutics USD -44.72M 54.62M 2026-03
Curis USD 19.36M 33.34M 2025-12
Sanofi EUR 2B 3.16B 2026-03
TG Therapeutics USD 20.36M 24.73M 2026-03
United Therapeutics USD 444M 6M 2025-12